Cargando…

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia

Essential thrombocythemia, as defined by the WHO in 2016, is a Philadelphia-negative chronic myeloproliferative neoplasm showing a better prognosis than polycythemia vera and myelofibrosis. In a variable percentage, patients with essential thrombocythemia show none of the known driver-gene mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Marco, Accurso, Vincenzo, Mancuso, Salvatrice, Napolitano, Mariasanta, Mattana, Marta, Vajana, Giorgia, Russello, Federica, Siragusa, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498770/ https://www.ncbi.nlm.nih.gov/pubmed/36135321 http://dx.doi.org/10.3390/hematolrep14030037

Ejemplares similares

Familial essential thrombocythemia: 6 cases from a mono‐institutional series
por: Accurso, Vincenzo, et al.
Publicado: (2022)

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
por: Accurso, Vincenzo, et al.
Publicado: (2020)

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
por: Mancuso, Salvatrice, et al.
Publicado: (2020)

Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
por: Accurso, Vincenzo, et al.
Publicado: (2020)

Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate
por: Napolitano, Mariasanta, et al.
Publicado: (2017)

Immunosenescence and lymphomagenesis
por: Mancuso, Salvatrice, et al.
Publicado: (2018)

Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
por: Accurso, Vincenzo, et al.
Publicado: (2019)

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system
por: Accurso, Vincenzo, et al.
Publicado: (2019)

Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs
por: Mancuso, Salvatrice, et al.
Publicado: (2018)

Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy
por: Mancuso, Salvatrice, et al.
Publicado: (2022)

Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review
por: Santoro, Marco, et al.
Publicado: (2021)

Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma
por: Mancuso, Salvatrice, et al.
Publicado: (2022)

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
por: Mancuso, Salvatrice, et al.
Publicado: (2020)

Patient with clinical celiac disease mimicking triple‐negative essential thrombocythemia
por: Ali, Elrazi A., et al.
Publicado: (2022)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia
por: Yıldız, Jale, et al.
Publicado: (2022)

Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia
por: Inano, Tadaaki, et al.
Publicado: (2021)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis
por: Napolitano, Mariasanta, et al.
Publicado: (2023)

Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia
por: Inano, Tadaaki, et al.
Publicado: (2022)

Individual with concurrent chest wall tuberculosis and triple-negative essential thrombocythemia: A case report
por: Xu, Xiao-Yan, et al.
Publicado: (2023)

Moyamoya syndrome in an adult with essential thrombocythemia
por: Lazzaro, Marc A., et al.
Publicado: (2011)

Essential thrombocythemia: Rare cause of chorea
por: Venkatesan, Eswaradass Prasanna, et al.
Publicado: (2014)

Mutant calreticulin causes essential thrombocythemia
por: Shimoda, Kazuya, et al.
Publicado: (2017)

Essential thrombocythemia treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Essential Thrombocythemia Presenting as Paraneoplastic Glomerulonephritis
por: Abdulla, M. C., et al.
Publicado: (2018)

Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements
por: Mattana, Marta, et al.
Publicado: (2022)

Triple-Negative Essential Thrombocythemia Complicated by Thrombosis and Acquired von Willebrand Disease in a Young Man
por: Kanderi, Tejaswi, et al.
Publicado: (2020)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
por: Cattaneo, Daniele, et al.
Publicado: (2021)

Prediction of major bleeding events in 1381 patients with essential thrombocythemia
por: Stuckey, Ruth, et al.
Publicado: (2023)

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy
por: Napolitano, Mariasanta, et al.
Publicado: (2017)

Cerebral Dissecting Aneurysms in Patients with Essential Thrombocythemia
por: Baek, Jin Wook, et al.
Publicado: (2014)

Essential thrombocythemia: a rare disease in childhood
por: Beatrice, Julia Maimone, et al.
Publicado: (2013)

Recent advances in understanding myelofibrosis and essential thrombocythemia
por: Vainchenker, William, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cac3ec0qmvicjn39pa46a16mfb